VIDEO and FREE TRIAL
Qlucore Omics Explorer video
Qlucore Omics Explorer free trial
Qlucore is working in various partnerships to advance specific disease sub-classification diagnostic tools for clinical use. In keeping with our powerful yet easy-to-use and highly visual core software, Qlucore Diagnostics solutions are being designed to improve clinic and staff capabilities in RNA-seq, transcriptomic-based or molecular-based diagnostics.
The first application area for the Qlucore Diagnostics platform is RNA-seq based cancer diagnostics in Acute Lymphoblastic Leukemia (BCP-ALL), including both gene expression subtype classification of B-cell leukemias and gene fusion analysis support. Work is ongoing to certify it for compliance with IVDR regulation (CE).
Qlucore Diagnostics is a scalable diagnostic solution from data to report, with machine learning based subtype classification combined with tailored reporting and visualization for clear communication between lab, clinicians, and patients.
The first application area for the Qlucore Diagnostics platform is RNA-seq based cancer diagnostics in Acute Lymphoblastic Leukemia, including both gene expression subtype classification of B-cell leukemias and gene fusion analysis support.
Work is ongoing to certify Qlucore Diagnostics for Acute Lymphoblastic Leukemia to comply with the IVDR regulation (CE).
The output of Qlucore Diagnostics is highly tailored to each disease area. The base is a pdf report that includes conclusions, results, plots, quality metrics and method information. Visualizations are included in the clinical report for communication between a molecular genetics lab, clinicians and patients.
View a draft example of how a report might look. Note that the example report is generated with Qlucore Insights (Research Use Only).